Clinical Trial Update: A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of BPI-371153 in advanced solid tumors and lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Lymphoma
• Non-small Cell Lung Cancer

Drugs mentioned

• BPI-371153 (BPI-371153)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Advanced Solid Tumor, Lymphoma | Phase 1 | Status: RECRUITING